1. Axelrod, J., and Saavedra, J. M. (1974). Octopamine, phenylethanolamine, phenylethylamine and tryptamine in the brain.Ciba Found. Symp. (New Ser.)2251?59.
2. Azzaro, A. J. and Demarest, K. T. (1982). Inhibiting effects of type A and type B monoamine oxidase inhibitors on synaptosomal accumulation of [3H]dopamine: A reflection of antidepressant potency.Biochem. Pharmacol. 312195?2197.
3. Baker, G. B., McKim, H. R., Calverley, D. G., and Dewhurst, W. G. (1978). Effects of the monoamine oxidase inhibitors tranylcypromine, phenelzine and pheniprazine on the uptake of catecholamines in slices from rat brain regions.Proc. Eur. Soc. Neurochem. 1536.
4. Baker, G. B., Hiob, L. E., and Dewhurst, W. G. (1980). Effects of monoamine oxidase inhibitors on release of dopamine and 5-hydroxytryptamine from rat striatumin vitro.Cell. Mol. Biol. 26182?186.
5. Baker, G. B., LeGatt, D. F., and Coutts, R. T. (1984). A comparison of the effects of acute and chronic administration of phenelzine and tranylcypromine on brain concentrations of 2-phenylethylamine,p-tyramine and tryptamine in the rat. InNeurobiology of the Trace Amines (A. A. Boulton, G. B. Baker, W. G. Dewhurst, and M. Sandler, Eds.), Humana Press, Clifton, N.J., pp. 277?282.